U.S. flag

An official website of the United States government

NM_000372.5(TYR):c.425A>T (p.Lys142Met) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Sep 15, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003557652.2

Allele description [Variation Report for NM_000372.5(TYR):c.425A>T (p.Lys142Met)]

NM_000372.5(TYR):c.425A>T (p.Lys142Met)

Gene:
TYR:tyrosinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q14.3
Genomic location:
Preferred name:
NM_000372.5(TYR):c.425A>T (p.Lys142Met)
HGVS:
  • NC_000011.10:g.89178378A>T
  • NG_008748.1:g.5507A>T
  • NM_000372.5:c.425A>TMANE SELECT
  • NP_000363.1:p.Lys142Met
  • NC_000011.9:g.88911546A>T
Protein change:
K142M
Molecular consequence:
  • NM_000372.5:c.425A>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004296102Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Sep 15, 2023)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Four novel mutations of TYR gene in Chinese OCA1 patients.

Wang Y, Guo X, Li W, Lian S.

J Dermatol Sci. 2009 Jan;53(1):80-1. doi: 10.1016/j.jdermsci.2008.07.002. Epub 2008 Aug 12. No abstract available.

PubMed [citation]
PMID:
18701257

A comprehensive analysis reveals mutational spectra and common alleles in Chinese patients with oculocutaneous albinism.

Wei A, Wang Y, Long Y, Wang Y, Guo X, Zhou Z, Zhu W, Liu J, Bian X, Lian S, Li W.

J Invest Dermatol. 2010 Mar;130(3):716-24. doi: 10.1038/jid.2009.339. Epub 2009 Oct 29.

PubMed [citation]
PMID:
19865097
See all PubMed Citations (6)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004296102.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

This sequence change replaces lysine, which is basic and polar, with methionine, which is neutral and non-polar, at codon 142 of the TYR protein (p.Lys142Met). This variant is present in population databases (rs754250982, gnomAD 0.02%). This missense change has been observed in individual(s) with oculocutaneous albinism (PMID: 18701257, 19865097, 22097729, 31077556). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TYR protein function. Experimental studies have shown that this missense change affects TYR function (PMID: 27537549). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024